ASPEN PHARMACARE HOLDINGS LIMITED - Dealing in Securities by Directors

Dealing in Securities by Directors

ASPEN PHARMACARE HOLDINGS LIMITED
(Incorporated in the Republic of South Africa) (“Aspen
Holdings”)
Registration number: 1985/0002935/06
Share code: APN
ISIN: ZAE000066692
(“Aspen”)


DEALING IN SECURITIES BY DIRECTORS

In compliance with the JSE Limited Listings Requirements, the
following information is disclosed:

Director                         :   Stephen Saad
Company                          :   Aspen Pharmacare Holdings
                                     Limited
Date of transaction              :   19 October 2018
Nature of transaction            :   On-market purchase
Class of securities              :   Ordinary shares
Number of securities             :   600 000
Volume Weighted Average Price    :   R156.46
Highest price                    :   R157.74
Lowest price                     :   R154.09
Value Transaction                :   R93 876 000
Nature of interest               :   Direct beneficial
Clearance obtained               :   Yes


Director                         :   Gus Attridge
Company                          :   Aspen Pharmacare Holdings
                                     Limited
Date of transaction              :   19 October 2018
Nature of transaction            :   On-market purchase
Class of securities              :   Ordinary shares
Number of securities             :   100 000
Volume Weighted Average Price    :   R156.46
Highest price                    :   R157.74
Lowest price                     :   R154.09
Value Transaction                :   R15 646 000
Nature of interest               :   Direct beneficial
Clearance obtained               :   Yes

Durban
19 October 2018

Sponsor
Investec Bank Limited

Date: 19/10/2018 02:44:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.